Clinical Trial Update: Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating macitentan in pulmonary arterial hypertension to psychometrically validate the PAH-SYMPACT instrument has completed with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Macitentan (macitentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2018-10-31